Diese Veranstaltung hat bereits stattgefunden
KongressRetina World Congress 2019
An event for ophthalmologistsFL 33316 Fort Lauderdale , USA
Kategorie:
Zum Kalender hinzufügen
-
Datum
21.03.2019, 08:00 - 24.03.2019, 12:00Veranstalter
MCME Global, Inc.Kurzbeschreibung
Retina World Congress is a non-profit organization dedicated to uniting international professionals to foster dialogue and to generate consensus about retinal diseases, emerging technologies and treatments, best practices and clinical research. Their biennial meeting is their main initiative and has brought together 150 faculty and 1,000 attendees from 32 U.S. states, 74 countries and 39 retina societies from around the globe. Again in 2019 to share research, innovations and ideas.Hinweis
\r\nParticipants must complete an online evaluation to receive a CME Certificate documenting AMA PRA Category 1 Credit(s)™ earned for attending sessions.\r\n\r\nINTERNATIONAL NOTICE: This educational activity is designated for AMA PRA Category 1 Credit(s)™ for all US physicians. All physicians will receive a CME certificate and non-US physicians should contact their respective organizations for reciprocity of credit.Gebühren
Fachärzte
Teilnehmer max.
unbegrenzt
Gebühren ab
839,00 USD
Earlybird bis 15.01.2019
739,00 USD
Hinweis
Retina Unplugged:
"RWC Attendee – FREE!
Non-attendee Physician – $325
Non-attendee Resident – $125
Non-attendee Corporate – $425"
Social Reception:
"RWC Attendee – FREE!
Non-attendee rates coming soon"
Ärzte/-innen in Weiterbildung
Teilnehmer max.
unbegrenzt
Gebühren ab
839,00 USD
Earlybird bis 15.01.2019
739,00 USD
Hinweis
Retina Unplugged:
"RWC Attendee – FREE!
Non-attendee Physician – $325
Non-attendee Resident – $125
Non-attendee Corporate – $425"
Social Reception:
"RWC Attendee – FREE!
Non-attendee rates coming soon"
Studenten/-innen
Teilnehmer max.
unbegrenzt
Gebühren ab
339,00 USD
Earlybird bis 15.01.2019
239,00 USD
Hinweis
Retina Unplugged:
"RWC Attendee – FREE!
Non-attendee Physician – $325
Non-attendee Resident – $125
Non-attendee Corporate – $425"
Social Reception:
"RWC Attendee – FREE!
Non-attendee rates coming soon"
Industriemitarbeiter/-innen
Teilnehmer max.
unbegrenzt
Gebühren ab
1.039,00 USD
Earlybird bis 15.01.2019
839,00 USD
Hinweis
Retina Unplugged:
"RWC Attendee – FREE!
Non-attendee Physician – $325
Non-attendee Resident – $125
Non-attendee Corporate – $425"
Social Reception:
"RWC Attendee – FREE!
Non-attendee rates coming soon"
-
THURSDAY, MARCH 21 Ocular Oncology 1:10 pm – 1:17 pm Management of High-risk Choroidal Melanoma Carol L. Shields, MD 1:17 pm – 1:24 pm
Invisible Tumors or Giant Iris Melanocyte Jerry A. Shields, MD 1:24 pm – 1:31 pm Using Imaging to Help Diagnose Ocular TumorsRubens N. Belfort, MD, PhD Rubens N. Belfort, MD, PhD 1:31 pm – 1:38 pm
Anti-VEGF Therapy for Radiation Retinopathy Prithvi Mruthyunjaya, MD, MHS 1:38 pm – 1:45 pm Choroidal Nevus Risk Factors: Weighted Relevance Based on Molecular Prognostication J. William Harbour, MD 1:45 pm – 1:52 pm
The Expanding Use of Ophthalmic Artery Chemosurgery Timothy G. Murray, MD, MBA 1:52 pm – 1:59 pm Future Therapeutics for Ocular Oncology Arun D. Singh, MDA 1:59 pm – 2:06 pm
Abstract Presentation 2:06 pm – 2:20 pm
Panel Discussion: Surgical and Medical Management of Ocular Oncology Cases Moderator: Arun D. Singh, MD Macular Surgery 2:25 pm – 2:32 pm Pneumatic vs. Chemical Approaches to Vitreomacular Traction Speaker To Be Announced
2:32 pm – 2:39 pm
Ectopic Inner Foveal Layers in ERMs, Surgical Results Andrea Govetto, MD, PhD
2:39 pm – 2:46 pm
Submacular Irrigation for Large Macular Holes Mario J. Saravia, MD
2:46 pm – 2:53 pm
Development of a Deep Learning System for Digitally Enhanced Internal
Limiting Membrane PeelingKazuaki Kadonosono, MD, PhD
2:53 pm – 3:00 pm
Approach to Lamellar Macular Hole Repair Yuki Morizane, MD, PhD
3:00 pm – 3:07 pm
Inverted ILM Flap Techniques and Indications Jerzy Nawrocki, MD, PhD
3:07 pm – 3:14 pm
Abstract Presentation
3:14 pm – 3:21 pm
Autologous Tissue Transplantation for Macular Holes Tamer H. Mahmoud, MD, PhD
3:21 pm – 3:28 pm
Surgical Management of AMD in Anti-VEGF Era Cesare Marriotti, MD
3:28 pm – 3:35 pm
Optic Pits Leandro C. Zacharias, MD, PhD
3:35 pm – 3:42 pm
Managing Myopic Foveoschisis: Surgery or Observation Yusuke Oshima, MD, PhD
3:42 pm – 3:49 pm
Abstract Presentation
3:49 pm – 3:56 pm
Abstract Presentation
3:56 pm – 4:15 pm
Panel Discussion Moderator: Gaurav K. Shah, MD Medical Retina: Retinal Vein Occlusion 4:20 pm – 4:27 pm
Effect of Anti-VEGF and Steroids Treatment on Retinal Non-perfusion Jorge C. P. Rocha, MD, PhD
4:27 pm – 4:34 pm
SCORE-2 Results and Implications to Clinical Practice Michael S. Ip, MD
4:34 pm – 4:41 pm
Addressing RVO with Corticosteroids Baruch D. Kuppermann, MD, PhD
4:41 pm – 4:48 pm
Comparative Studies of Treatments for RVO: LEAVO Study Results
4:48 pm – 4:55 pm
Abstract Presentation
4:55 pm – 5:02 pm
Abstract Presentation
5:02 pm – 5:09 pm
Abstract Presentation
5:09 pm – 5:16 pm Abstract Presentation
5:16 pm – 5:45 pm
Panel Discussion Moderator: Marcio B. Nehemy, MD, PhD FRIDAY, March 22 Surgical Technology 8:00 am – 8:07 am
Scleral Fixation of In-the-bag Luxated or Subluxated IOLs Martin Charles, MD
8:07 am – 8:14 am
Intraoperative OCT: Where Do We Stand?
8:14 am – 8:21 am
Hybrid Wide-angle Viewing and Endoscopic Vitrectomy Using a
3D Visualization SystemMihori Kita, MD, PhD
8:21 am – 8:28 am Science of 3D Visualization Systems David R. Chow, MD, FRCSC
8:28 am – 8:35 am
Advancements in Visualization in VR Surgery Khalid Al-Sabti, MD, FRCSC
8:35 am – 8:56 am
Panel Discussion: Instrumentation in the OR Moderator: David R. Chow, MD, FRCSC Retinal Detachment Surgery 9:00 am – 9:07 am
Temporal Keratoprothesis and Vitrectomy Andres Bastien, MD
9:07 am – 9:14 am
Chandelier Illumination for Scleral Buckling Nur Acar Gocgil, MD, Prof, FEBO
9:14 am – 9:21 am
Management of Retinal Detachment in Pediatric Age Ehab N. El Rayes, MD, PhD
9:21 am – 9:28 am
The Art and Science of YAG Vitreolysis Kirk H. Packo, MD
9:28 am – 9:35 am
Retinal Detachment from Macular Hole Marcio B. Nehemy, MD, PhD
9:35 am – 10:02 am
ILM Peeling During Retinal Detachment Surgery: Is It Necessary? Ezequiel Rosendi, MD
10:02 am – 10:09 am
Abstract Presentation
10:09 am – 10:16 am
Abstract Presentation
Imaging 10:35 am – 10:42 am
Artificial Intelligence in OCT Imaging Javier Zarranz-Ventura, MD, PhD, FEBO
10:42 am – 10:49 am
Artificial Intelligence and Choroidal Imaging Taiji Sakamoto, MD, PhD
10:49 am – 10:56 am
Angiogenic Biomarkers in Neovascular AMD Luiz H. Lima, MD
10:56 am – 11:03 am
Quantitative Comparison of UWF Imaging Devices Ajay E. Kuriyan, MD, MS
11:03 am – 11:10 am
How Optical Coherence Angiography Changes My Practice Miho Nozaki, MD, PhD
11:10 am – 11:17 am
Agreement between OCT Angiography and FA/ICG in Neovascular AMD Nadia K. Waheed, MD, MPH
11:17 am – 11:24 am
Mac Tel 2: A Multimodal Imaging Journey Lihteh Wu, MD
11:24 am – 11:31 am
OCT Angiography in CNV: Are There Parameters that
Predict Anti-VEGF Treatment Frequency?Amani A. Fawzi, MD
11:31 am – 11:38 am
Multimodal Imaging in Polypoidal Choriodovasculopathy Seung-Young Yu, MD, PhD
11:38 am – 11:45 am
Comparison of Ultra-widefield Imaging Devices Claudia Acosta, MD
1:15 pm – 1:22 pm
Ultra-widefield Imaging and Diabetic Retinopathy Justis P. Ehlers, MD
1:22 pm – 1:29 pm
Ultra-widefield OCTA and Retinal Vein Occlusion Kasra A. Rezaei, MD
1:29 pm – 1:36 pm
Adaptive Optics Imaging in a Retina Practice Mina M. Chung, MD
1:36 pm – 1:43 pm
Clinical Optimization of OCT-Angiography in Routine Practice Netan Choudhry, MD, FRCSC
1:43 pm – 1:50 pm
Multimodal Retinal Imaging for Alzheimer’s Disease Sharon Fekrat, MD
1:50 pm – 1:57 pm
Abstract Presentation
1:57 pm – 2:10 pm
Panel Discussion Moderator: Jay S. Duker, MD Age-related Macular Degeneration 2:15 pm – 2:22 pm
Drusen Ooze: New Hypothesis for Geographic Atrophy Growth
2:22 pm – 2:29 pm
AMD, Genetic Testing and AREDS Supplements Carl C. Awh, MD
2:29 pm – 2:36 pm
Prevention of Exudative AMD in High Risk Eyes Sumit P. Shah, MD
2:36 pm – 2:43 pm
Geographic Atrophy Associated with AMD, Incidence and
Factors Influencing Growth RateNancy Holenkamp, MD
2:43 pm – 2:50 pm
C3 Complement Inhibition for the Reduction of Growth in Geographic Atrophy Nathan C. Steinle, MD
2:50 pm – 2:57 pm
Impact of Genetics on AMD Conversion and Response
2:57 pm – 3:04 pm
Gene Therapy for Dry AMD Elias Reichel, MD 3:04 pm – 3:11 pm
Emerging Therapies on Dry AMD Paolo Lanzetta, MD
EXUDATIVE AMD
3:11 pm – 3:18 pm
Nonexudative Neovascular AMD: What Is It? Daniela Ferrara, MD, MSc, PhD
3:18 pm – 3:25 pm
Evaluating the Social Costs of Blindness from AMD Andrew A. Moshfeghi, MD, MBA
3:25 pm – 3:32 pm
Real-world Anti-VEGF Treatment for AMD Patricio P. Schlottmann, MD
3:52 pm – 3:59 pm
Angiopoietin Pathway in Neovascular Diseases Peter K. Kaiser, MD
3:59 pm – 4:06 pm Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Exudative AMD Carl D. Regillo, MD
4:06 pm – 4:13 pm
Gene Therapy for Exudative AMD
4:13 pm – 4:20 pm
A Comparison of Brolucizumab and Afibercept in Neovascular Age-related
Macular Degeneration: Important SubanalysesPravin U. Dugel, MD
4:20 pm – 4:27 pm
Stem Cell Therapy for AMD
4:27 pm – 4:34 pm
Emerging Therapies for Exudative AMD David S. Boyer, MD
4:34 pm – 4:41 pm
Abstract Presentation
4:41 pm – 4:48 pm
Abstract Presentation
4:48 pm – 5:12 pm
Panel Discussion Moderator: Rishi P. Singh, MD Diabetic Vitrectomy 5:12 pm – 5:19 pm
Intravitreal Anti-VEGF as an Adjunct to Vitrectomy Surgery for Diabetic Tractional
Retinal DetachmentJ. Fernando Arevalo, MD, FACS
5:19 pm – 5:26 pm
Vitrectomy for Diabetic Macular Edema Jay Chhablani, MD
5:26 pm – 5:33 pm
Role of Patient Compliance in the Development of Sight Threatening Diabetic Retinopathy Shwu-Jiuan Sheu, MD
5:33 pm – 5:40 pm
All-probe Vitrectomy Dissection Techniques for Diabetic Tractional Retinal Detachments:
Lift and ShaveMaria H. Berrocal, MD
5:40 pm – 5:47 pm
3D Surgery for Diabetic Surgery Marco Mura, MD
5:47 pm – 5:54 pm
Advanced Maneuvers in Proliferative Diabetic Surgery Andre V. Gomes, MD, PhD
5:54 pm – 6:01 pm
Steroid Drops after Vitreoretinal Surgery: Is It Time To Go Drop-less? John S. Pollack, MD
6:01 pm – 6:08 pm
Abstract Presentation
6:08 pm – 6:30 pm
Panel Discussion Moderator: Kourous A. Rezaei, MD SATURDAY, March 23 Trauma and Proliferative Vitreoretinopathy Surgery 8:00 am – 8:07 am
Re-examination of the Role of Relaxing Retinotomy in PVR Detachment Repair Grazia Pertile, MD
8:07 am – 8:14 am
Severe Trauma Cases: Pearls and Tricks Carl C. Claes, MD
8:14 am – 8:21 am
Ocular Trauma: New Updates Sundaram Natarajan, MD
8:21 am – 8:28 am
Pharmaceutical Management of PVR Demetrios G. Vavvas, MD, PhD
8:28 am – 8:35 am
Is Scleral Buckling Necessary? Gaurav K. Shah, MD
8:35 am – 8:42 am
Management of Subretinal Perfluorocarbon Liquid Leonardo B. Oliveira, MD
8:42 am – 8:49 am
Use Perfluorocarbon as a Tamponade Agent Stanislao Rizzo, MD
8:49 am – 8:56 am
Treatment of Persistent Hypotony in PVR Eyes Tarek S. Hassan, MD
8:56 am – 9:03 am
Strategy for the Primary PVR Surgery Motohiro Kamei, MD, PhD
9:03 am – 9:10 am
Abstract Presentation
9:10 am – 9:17 am
Abstract Presentation
9:17 am – 9:40 am
Panel Discussion Moderator: Moderator: Nur Acar Gocgil, MD Medical Retina: Diabetic Macular Edema and Diabetic Retinopathy 10:00 am – 10:07 am
Dual Approach for DME: Findings from Faricimab Dilsher S. Dhoot, MD
10:07 am – 10:14 am
Identifying Eyes that will Develop Vision Threatening Retinopathy Patricia Udaondo, MD
10:14 am – 10:21 am
Long-term Outcomes of Anti-VEGF Therapy for Proliferative Diabetic Retinopathy:
Year 5 Protocol S OutcomesJeffrey G. Gross, MD
10:21 am – 10:28 am
The Value of Treating Non-proliferative Diabetic Retinopathy Lloyd W. Clark, MD
10:28 am – 10:35 am
Rescuing those with Poor Anti-VEGF Treatment Response Daniel F. Martin, MD
10:35 am – 10:42 am
Long-term Anti-VEGF Treatment Outcomes
10:42 am – 10:49 am
Matching Diabetic Choroidopathy to Retinopathy: A Classification System of OCT Findings Lilianne G. Duarte, MD, PgD
10:49 am – 10:56 am
Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema
10:56 am – 11:03 am
Peripheral Diabetic Retinopathy as a Risk Factor for the Progression of Diabetic Retinopathy
11:03 am – 11:10 am
Integrin Antagonism for DME Hugo Quiroz-Mercado, MD
11:10 am – 11:17 am
Kallikrein Inhibitors for DME Victor H. Gonzalez, MD
11:17 am – 11:24 am
Abstract Presentation
11:24 am – 11:31 am
Abstract Presentation
11:31 am – 11:45 am
Panel Discussion Moderator: To Be Announced Controversies and Debates 1:15 pm – 1:21 pm Is Digital Visualization Surgery Necessary in Practice? Pro: Flavio A. Rezende, MD, PhD
Con: Raja Narayanan, MD, MBA1:21 pm – 1:26 pm
Question & Answer
1:26 pm – 1:32 pm
Is It Necessary to Limit Internal Membrane Flaps in Macular Hole Surgery? Pro: Anthanasios Nikolakopoulos, MD
Con: John W. Kitchens, MD1:32 pm – 1:37 pm
Question & Answer
1:37 pm – 1:43 pm
Is Intraoperative OCT Ready for Prime Time? Pro: Susanne Binder, MD
Con: Magno A. Ferreira, MD, MsC, MBA, PhD1:43 pm – 1:48 pm
Question & Answer
1:48 pm – 1:54 pm
Is Scleral Buckling Still a Useful Technique? Pro: Marcos P. Ávila, MD
Con: Fabio Patelli, MD1:54 pm – 1:59 pm
Question & Answer
1:59 pm – 2:05 pm
What is the First Line of Treatment for Center Involved DME? Steroids: Laurent Kodjikian, MD, PhD, FEBO
Anti-VEGF: Marcelo Zas, MD, PhD2:05 pm – 2:10 pm
Question & Answer
2:10 pm – 2:16 pm
Should Vitrectomy be the Primary Therapy for Endophthalmitis? Pro: Ferenc Kuhn, MD, PhD
Con: William E. Smiddy, MD2:16 pm – 2:21 pm
Question & Answer
2:21 pm – 2:27 pm
What is the First Line of Treatment for Chronic CSCR? PDT: Speaker To Be Announced
Mineralocorticoid-receptor Antagonists:
Francine Behar-Cohen, MD, PhD
Micropulse Laser: Jose A. Roca, MD2:27 pm – 2:35 pm
Question & Answer
2:55 pm – 3:01 pm What is the First Line of Treatment for PCV? PDT plus Anti-VEGF: Gregg T. Kokame, MD
Anti-VEGF Monotherapy: Speaker To Be Announced3:01 pm – 3:06 pm
Question & Answer
3:06 pm – 3:12 pm
Is Telemedicine for Ophthalmology Evaluations Ready for Prime Time? Pro: Alexandre Taleb, MD, PhD
Con: Francisco Rodrigues, MD3:12 pm – 3:17 pm
Question & Answer
3:17 pm – 3:23 pm
Is Pneumatic Retinopexy Useful? Pro: Rajeev H. Muni, MD, MSc, FRCSC
Con: Michael Kapusta, MD3:23 pm – 3:30 pm
Question & Answer
RETINAWS 3:30 pm – 4:30 pm Join us for a video-oriented surgical course where we’ll discuss complex
vitreoretinal surgery, rare surgical cases and unique surgical techniques.Early Career Session 4:30 pm – 5:30 pm Social Media for Collaboration: Young Retina Forum Survey Results Hemang K. Pandya, MD How to Gain an Audience Outside of the Podium Jayanth Sridhar, MD Getting Started with Clinical Research in Private Practice Chirag Jhaveri, MD Choose Your Own Adventure: Case Presentations Sumit Sharma, MD; Eduardo Uchiyama, MD International Collaboration: Panel Discussion Jorge A. Fortun, MD; Chirag Jhaveri, MD;
Mitul Mehta, MD, MS; Raja Narayanan, MBBS,
MS; Hemang K. Pandya, MD; Sumit Sharma, MDSUNDAY, March 24 Pediatrics, Pediatric Surgery, Gene Therapy and Upcoming Technologies 8:00 am – 8:07 am
New Therapy Approaches for Retinopathy of Prematurity Darius M. Moshfeghi, MD
-
Fort Lauderdale Marriott Harbor Beach Resort & Spa
MCME Global, Inc.
Meeting Services Coordinator: Yolanda Anderson
2550 Fifth Ave, Ste 145
US - CA 92103 San Diego
Tel.: +1 619 344 6971
Fax: +1 619 564 7290 -
Registration required. Please contact the organizer for further information.